Albert J. Augustin, Silvia Bopp, Martin Fechner, Frank Holz, Dirk Sandner, Andrea Winkgen, Ramin Khoramnia, Thomas Neuhann, Marcus Warscher, Martin Spitzer, Walter Sekundo, Berthold Seitz, Tobias Duncker, Christian Ksinsik, Helmuth Höh, Daniela Gentsch
- Introduction: The Retro-IDEAL (ILUVIEN Implant for chronic DiabEtic MAcuLar edema) study is a retrospective study designed to assess real-world outcomes achieved with the ILUVIEN® (0.19 mg fluocinolone acetonide (FAc)) in patients with chronic diabetic macular edema (DME) in clinical practices in Germany.
Methods: This study was conducted across 16 sites in Germany and involved 81 eyes (63 patients) with persistent or recurrent DME and a prior suboptimal response to a first-line intravitreal therapy (primarily anti-VEGF intravitreal therapies).
Results: Patients were followed-up for 30.8 ± 11.3 months (mean ± standard deviation) and had a mean age of 68.0 ± 10.4 years. Best-recorded visual acuity (BRVA) improved by +5.5 letters at month 9 (P ⩽ 0.005, n=56; from a baseline of 49 letters) and this was maintained through to month 30 (P ⩽ 0.05, n = 42). There was a concurrent improvement in central macular thickness with a reduction from 502 µm at baseline to 338 µm at year 1 (P ⩽ 0.0001, n = 43). This effect was sustained to year 3 (i.e. 318 µm; P ⩽ 0.0001, n = 29). Mean intraocular pressure (IOP) remained constant between baseline and year 3 with a peak change of 1.9 mm Hg occurring at year 1. Elevated IOP was observed in a similar percentage of patients prior to (22.2% of cases) and following (27.2%) treatment with the FAc implant. In the majority of cases, these elevations were managed effectively with IOP medications.
Conclusions: Despite substantial amounts of prior intravitreal treatments – primarily with anti–vascular endothelial growth factor (VEGF) drugs – this real-world study showed that sustained structural and functional improvements can last for up to 3 years with a single FAc implant.
MetadatenVerfasserangaben: | Albert J. Augustin, Silvia Bopp, Martin Fechner, Frank Holz, Dirk Sandner, Andrea Winkgen, Ramin Khoramnia, Thomas Neuhann, Marcus Warscher, Martin Spitzer, Walter Sekundo, Berthold Seitz, Tobias Duncker, Christian Ksinsik, Helmuth Höh, Daniela Gentsch |
---|
URN: | urn:nbn:de:hebis:30:3-500310 |
---|
DOI: | https://doi.org/10.1177/1120672119834474 |
---|
ISSN: | 1724-6016 |
---|
ISSN: | 1120-6721 |
---|
Pubmed-Id: | https://pubmed.ncbi.nlm.nih.gov/30884972 |
---|
Titel des übergeordneten Werkes (Englisch): | European journal of ophthalmology |
---|
Verlag: | Sage |
---|
Verlagsort: | Thousand Oaks, Calif. |
---|
Dokumentart: | Wissenschaftlicher Artikel |
---|
Sprache: | Englisch |
---|
Jahr der Fertigstellung: | 2019 |
---|
Datum der Erstveröffentlichung: | 18.03.2019 |
---|
Veröffentlichende Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Datum der Freischaltung: | 23.04.2019 |
---|
Freies Schlagwort / Tag: | 3years; DME; ILUVIEN; Retro-IDEAL; Steroid; microdosing |
---|
Jahrgang: | 29 |
---|
Seitenzahl: | 10 |
---|
Erste Seite: | 1 |
---|
Letzte Seite: | 10 |
---|
Bemerkung: | This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
---|
HeBIS-PPN: | 45377329X |
---|
Institute: | Medizin / Medizin |
---|
DDC-Klassifikation: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Lizenz (Deutsch): | Creative Commons - Namensnennung 4.0 |
---|